NNW Headlines
Save 20% on Press Releases and More with NNW Prime! Click to View Details
Home » NewsRoom » NewsRoom Articles
MondayMar 13, 2017 6:00 pm

LivePerson, Inc. (NASDAQ: LPSN) Starts Presentation at 29th Annual ROTH Conference

LivePerson (NASDAQ: LPSN) provides mobile and online messaging technologies that power digital communication between brands and consumers in the United States, in the United Kingdom, the Asia-Pacific, Latin America and Western Europe. The Business segment facilitates real-time online interactions, such as chat, voice, messaging, and content delivery, across multiple channels and screens for corporations of all sizes. The Consumer segment facilitates online transactions between independent service providers and individual consumers seeking information and knowledge via mobile and online messaging. Its cloud-based platform is LiveEngage, which enables businesses to create a connection with consumers by offering messaging as a preferred channel…

Continue Reading

MondayMar 13, 2017 6:00 pm

Depomed, Inc. (NASDAQ: DEPO) Starts Presentation at 29th Annual ROTH Conference

Depomed (NASDAQ: DEPO) is a specialty pharmaceutical company focused on enhancing the lives of the patients, families, physicians, providers and payors through commercializing innovative products for pain and neurology related disorders. Depomed markets six medicines with areas of focus that include mild to severe acute pain, moderate to severe chronic pain, neuropathic pain, migraine and breakthrough cancer pain. Depomed is headquartered in Newark, California. For more information, visit the company’s website at www.depomed.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and…

Continue Reading

MondayMar 13, 2017 6:00 pm

Limbach Holdings, Inc. (NASDAQ: LMB) Starts Presentation at 29th Annual ROTH Conference

Limbach Holdings (NASDAQ: LMB) provides commercial specialty contractor services in the United States. The company provides services in the areas of HVAC (heating, ventilation, and air-conditioning), plumbing, electrical and building controls for the design and construction of new and renovated buildings, as well as maintenance services and equipment upgrades. Its facility services comprise mechanical construction, HVAC service and maintenance, energy audits and retrofits, engineering and design build, constructability evaluation, equipment and materials selection, offsite/prefab construction, and sustainable building solutions and practices. For more information, visit the company’s website at www.limbachinc.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced…

Continue Reading

MondayMar 13, 2017 5:30 pm

TransAct Technologies, Inc. (NASDAQ: TACT) Starts Presentation at 29th Annual Roth Conference

TransAct Technologies (NASDAQ: TACT) designs, develops, assembles and markets transaction-based and specialty printers and terminals in the United States and internationally. It offers thermal, inkjet and impact printers and terminals to generate food rotation date and nutritional labels, promotional coupons, and transaction records, such as receipts, tickets, register journals, and other documents, as well as for printed logging and plotting of oil field and drilling data. The company also provides consumable products, including inkjet cartridges, ribbons, receipt papers, color thermal papers, and other printing supplies, as well as replacement parts; maintenance, repair, and testing services; and refurbished printers. For more…

Continue Reading

MondayMar 13, 2017 5:30 pm

Fate Therapeutics, Inc. (NASDAQ: FATE) Starts Presentation at 29th Annual ROTH Conference

Fate Therapeutics (NASDAQ: FATE) is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders. The company's hematopoietic cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf product candidates derived from engineered induced pluripotent cell lines, and immuno-regulatory programs. Its adoptive cell therapy programs are based on the company's novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells. Fate Therapeutics is headquartered in San Diego, California. For more information, visit the company’s website at www.fatetherapeutics.com. About NetworkNewsWire NetworkNewsWire (NNW) provides…

Continue Reading

MondayMar 13, 2017 5:30 pm

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) Starts Presentation at 29th Annual ROTH Conference

AcelRx Pharmaceuticals (NASDAQ: ACRX) is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. An NDA for DSUVIA (sufentanil sublingual tablet, 30 mcg) was recently submitted to the FDA for review. The company’s follow on product, ZALVISO® (sufentanil sublingual tablet system), designed for the management of moderate-to-severe acute pain in adult patients in the hospital setting, is currently enrolling patients in a phase 3 clinical trial, IAP312. For more information, visit the company’s website at www.acelrx.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and…

Continue Reading

MondayMar 13, 2017 5:30 pm

Trecora Resources (NYSE: TREC) Starts Presentation at 29th Annual Roth Conference

Trecora Resources (NYSE: TREC) manufactures and sells various specialty petrochemical products and synthetic waxes in the United States. The Petrochemical segment produces hydrocarbons and other petroleum based products, including isopentane, normal pentane, isohexane, and hexane used in the production of polyethylene, packaging, polypropylene, expandable polystyrene, poly-iso/urethane foams, and crude oil from the Canadian tar sands, as well as in the catalyst support industry. The Specialty Waxes segment offers specialty polyethylene waxes used in the paints, inks, adhesives, coatings and PVC lubricants markets; and specialized synthetic poly alpha olefin waxes for use as toner in printers, as well as additives for…

Continue Reading

MondayMar 13, 2017 5:30 pm

Quantenna Communications, Inc. (NASDAQ: QTNA) Starts Presentation at 29th Annual Roth Conference

Quantenna Communications (NASDAQ: QTNA) designs, develops and markets wireless communication solutions enabling wireless local area networking for the telecommunications service provider market in the United States and internationally. Its solutions portfolio is comprised of radio frequency chips and digital baseband chips which support the IEEE Wi-Fi standards, including 802.11n and 802.11ac. The company offers its products for home networking applications including home gateways, repeaters, set-top boxes, small and medium business applications, enterprise networking applications and consumer electronics applications. The company sells its Wi-Fi solutions directly to original equipment manufacturers, original design manufacturers and third-party distributors. For more information, visit the…

Continue Reading

MondayMar 13, 2017 5:00 pm

Telit Communications PLC (TTCNF) Starts Presentation at 29th Annual Roth Conference

Telit Communications (OTC: TTCNF) operates in the field of the Internet of Things (IoT) and machine to machine communications in the EMEA, the APAC, and the Americas. It develops, manufactures, and markets communication modules, which enable machines, devices, and vehicles to communicate via cellular wireless networks. The company offers cellular, GNSS (location), short-to-long range wireless modules plus mobile connectivity services, and IoT application enablement platform to enable data collection and processing from edge devices. It provides solutions and applications for deployment in segments, including asset tracking, remote industrial monitoring, automated utility meter reading, insurance telematics, consumer electronics, mobile health devices…

Continue Reading

MondayMar 13, 2017 5:00 pm

Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) Starts Presentation at 29th Annual Roth Conference

Pieris Pharmaceuticals (NASDAQ: PIRS) is a clinical-stage biopharmaceutical company that discovers and develops Anticalin-based drugs. The company develops Anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in blood plasma and other bodily fluids. Pieris primarily focuses on the development of three drug candidates, including PRS-080 designed to target hepcidin for the treatment of functional iron deficiency in anemic patients with chronic kidney disease or in end-stage renal disease patients requiring dialysis; PRS-060, a drug candidate that binds to the IL-4RA receptor alpha-chain, which is used for the treatment…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

NetworkNewsWire

1108 Lavaca St
Suite 110-NNW
Austin, TX 78701
(512) 354-7000

Copyright 2015 - 2025. NetworkNewsWire® / 1108 Lavaca St Suite 110-NNW Austin, TX 78701 (512) 354-7000 / Disclaimers